Abstract 641105 subjects who have a twin with multiple sclerosis included in a study of clinical concordance also underwent MRI of the brain. 8/23 monozygotic and 1/41 dizygotic co-twins from this subgroup were clinically concordant of whom 819 had MRI appearances typical of multiple sclerosis. Of the 48 clinically discordant twins aged less than 60, abnormalities on MRI were detected in 6/15 (40%) monozygotic and 13133 (39%) dizygotic twins compared with 7/37 (19%) healthy agematched controls. Abnormalities on MRI typical of multiple sclerosis (defined by the Fazekas criteria) were, however, present in only 2115 (13%) monozygotic and 3133 (90/6) dizygotic twins and 0/37 controls. These results suggest that about 10% of monozygotic and dizygotic twins have "subclinical multiple sclerosis". It is likely that most of the MRI abnormalities seen in clinically discordant twins, however, represent incidental pathology. 
For a given disease, the determination of concordance rates in twins permits an estimation of the aetiological contribution made by genetic factors. ' Higher concordance rates in monozygotic than dizygotic twins indicate a genetic contribution, but if the monozygotic concordance rate is less than 100%, genetic factors alone, or at least those determined by the germ cell line, are not of themselves sufficient to cause the disease.
Several large studies of clinical concordance for multiple sclerosis in twins have been published.2-'2 Despite considerable methodological differences, a consistent pattern has emerged; most but not all studies have identified a higher concordance rate in monozygotic twins, and all are in accord that the monozygotic concordance rate falls well short of 100%. Two of the largest population based surveys2 1 produced remarkably similar results (25% monozygotic and 2-3% dizygotic concordance) although the recent French study'2 found low concordance rates that were independent of zygosity.
It might be concluded from the current twin data that although genetic factors make an important contribution to the aetiology of multiple sclerosis, additional environmental factors are probably needed to produce the disease. An important question in multiple sclerosis twin studies is the reliability of concordance rates that have been determined by an assessment of clinical features alone. The certainty of clinical diagnosis varies especially in the early stages, and this is reflected in the use of criteria that allow for definite, probable, and possible categories. Furthermore, and potentially of much greater importance, the disease may run an extremely benign course13-15 and indeed may first be discovered only at necropsy.'121 One postmortem series19 identified multiple sclerosis that had not been suspected in life with a frequency of 1 in 500, which suggests that completely asymptomatic disease may be as common as the clinically expressed form. Additional suggestive evidence for clinically silent multiple sclerosis during life comes from the finding of CSF oligoclonal bands in clinically unaffected twinS22 and abnormalities of evoked potentials in healthy siblings of patients with multiple sclerosis, especially those who are identical at the HLA-A and HLA-B loci.2' Taken together, the evidence suggests that clinical ascertainment alone fails to detect an appreciable number of cases who actually have multiple sclerosis.
MRI now provides a sensitive means for detecting, in vivo, the characteristic cerebral lesions of multiple sclerosis.2425 White matter lesions, most of which are asymptomatic, are seen in well over 90% of patients with clinically definite multiple sclerosis.26 Furthermore, multiple asymptomatic white matter lesions are already visible in 50%-70% of patients at presentation with a first episode of suspected demyelination27-3" and have also recently been reported in healthy first degree relatives of patients with multiple sclerosis.'2" MRI should therefore be of value in a multiple sclerosis twin study by detecting subclinical disease in clinically normal twins, leading to a more reliable estimate of concordance than that obtained from clinical criteria. It would also be useful in clarifying the diagnosis in clinically possible cases. A major limitation to using MRI to detect multiple sclerosis in asymptomatic subjects, however, is that the abnormalities seen are not specific; there are many causes of multifocal white matter lesions,3436 of which the most frequent is age-related changes, most likely due to small vessel disease.7A41 This produces abnormalities of white matter in a large proportion of healthy controls over the age of 60, and in smaller numbers of younger age groups.4245 To determine the significance of abnormalities seen in asymptomatic twins, it is therefore crucial to obtain MRI scans from age matched controls and to use criteria that improve the specificity of abnormalities detected by MRI in multiple sclerosis. We now report the brain MRI findings obtained in 64 co-twins of patients with multiple sclerosis and 40 healthy controls.
Methods

TWINS
The group consisted of 64 of the 105 co-twins interviewed and examined as described elsewhere.2 Briefly, recruitment (over a period of 28 months) was predominantly via members of the Association of British Neurologists, who were asked to ascertain of all patients with multiple sclerosis seen by them whether they were a twin. Index cases and co-twins were all assessed by one of us (CJM) who used a standardised questionnaire to obtain clinical details followed by a full neurological examination. All 105 co-twins were requested to attend for MRI: of the 64 who were scanned 23 were monozygotic aged 21-53 (mean 37 5 ) years (four men) and 41 dizygotic aged (mean 44 3) years (22 men). There were 21 monozygotic and 20 dizygotic (31 women) twins who were not scanned.
CONTROLS
The control group consisted of 40 healthy volunteers aged (mean 41-3) years (20 men). They were recruited from hospital staff and friends of patients attending the unit. Relatives of patients with multiple sclerosis were excluded. All filled in a general health questionnaire seeking evidence of previous neurological illness, hypertension, cerebrovascular or cardiovascular disease, and diabetes.
MRI
Most twins were imaged at the National Hospitals for Neurology and Neurosurgery (NHNN) on a Picker 0-5 T (24 subjects) or General Electric 1.5 T Signa system (28), provided by The Multiple Sclerosis Society of Great Britain and Northern Ireland. Smaller numbers were scanned in other centres in the United Kingdom on 0-15T (2), 0-5T (4), or 1-5T (6) systems.
Moderately T2-weighted 5 or 10 mm axial images of the brain were obtained in all cases and more proton density-weighted images in some subjects. For example, the imaging All the controls were imaged on the GE 1 5 T Signa scanner. In 21 T2 and proton density-weighted axial spin echo were obtained as described but in the remaining 19 fast spin echo images (either FSE3500119,95 or FSE3,100,76) were obtained instead.
All images, with controls and twins interdigitated, were interpreted by one of us (BEK) without reference to the clinical history. A scan was judged to be abnormal if there were one or more areas of unequivocal high signal in the brain parenchyma compatible with demyelination. The site and size of every such lesion was noted. Abnormalities on MRI that were obviously not due to demyelination (for example, incidental arachnoid cysts) were ignored. To improve the specificity of MRI for detecting multiple sclerosis, those with an abnormal scan were classified separately according to whether or not they fulfilled the criteria of Fazekas et al. 46 With this system, MRI diagnosis of multiple sclerosis requires the presence of any two out of three abnormalities: (a) a lesion adjacent to the body of the lateral ventricles; (b) an infratentorial lesion; (c) a lesion greater than or equal to 6 mm in diameter. Previous evaluation of these criteria in 1500 consecutive patients reported a sensitivity of 81% and specificity of 96% for the diagnosis of multiple sclerosis.4
Results
CLINICAL FEATURES
The mean age of the twins scanned was 41-8 (SD 10.4) and of the controls 41 (fig 1) , and six fulfilled the criteria of Fazekas et a146 (four definite, one probable, and one possible multiple sclerosis). Figure 
One twin with definite and one with probable multiple sclerosis displayed multiple small (4 5mm) cerebral white matter lesions characteristic of multiple sclerosis, but there were no infratentorial or larger lesions to satisfy the criteria. One twin with clinically possible multiple sclerosis showed a single lesion in the cerebral white matter. Eight of nine therefore had an abnormal scan typical of multiple sclerosis.
In three twins, MRI increased the diagnostic There was no significant effect of magnet field strength on the number of lesions detected.
Discussion MRI was used in the present study to ascertain the frequency of clinically silent abnormalities thought likely to be due to multiple sclerosis and thereby to consolidate and extend the concordance rates that had already been calculated from clinical criteria alone.
One limitation is that we were only able to obtain MRI on 9/11 (82%) clinically affected and 55/94 (59%) of the clinically unaffected co-twins of index cases included in the clinical study.2 Twins who were scanned had demographic characteristics similar to the entire cohort, however, and it seems reasonable to regard them as representative of the larger group. In particular, it should be emphasised that the 55 clinically unaffected co-twins who participated in the MRI study had all been screened by a clinician and did not have neurological symptoms or signs; this cohort was therefore unlikely to be biased through willingness to undergo MRI as a result of personal anxiety about disease.
The MRI was diagnostically useful in the 8/9 clinically affected twins of patients with multiple sclerosis who were examined. It displayed one or more lesions compatible with multiple sclerosis, however, in all nine, and in none did it reveal alternative diagnoses to account for the symptoms. In three, the diagnostic category of multiple sclerosis was made more certain after the MRI result was taken into account.
In evaluating the significance of abnormalities on MRI in the clinically unaffected twins, it is necessary to consider their age.
Numerous surveys on healthy subjects aged over 60 have revealed a high frequency shown to be at their least specific among the elderly subjects. 47 It is likely that most of the MRI abnormalities seen in these seven elderly dizygotic twins are due to incidental agerelated vascular disease, but the possibility that some are due to multiple sclerosis cannot be excluded. To achieve a reasonable degree of specificity for multiple sclerosis, however, it is wise to confine the analysis to younger adults (aged less than 60).
If it is assumed that all twins aged less than 60 with an abnormal scan actually have multiple sclerosis, the overall (clinical plus radiological) concordance rate would be 55% for monozygotic and 41% for dizygotic twins. If the stricter criteria of Fazekas et a146 are applied for MRI diagnosis, the overall concordance rates are 34% and 12% for monozygotic and dizygotic twins respectively.
Several previous studies have reported MRI findings in clinically unaffected twins of patients with multiple sclerosis. Kinnunen et al49 found no abnormalities on low field strength MRI in five monozygotic and six dizygotic clinically unaffected twins, McFarland et al50 in 1/3 monozygotic and 0/1 dizygotic (MRI was also normal in the clinically affected member of the dizygotic pair) and Uitdehaag et al51 in 3/4 monozygotic and 0/3 dizygotic. These are small numbers, and the last two studies recruited subjects by public appeal, which introduces an important ascertainment bias. The recent French12 and Canadian update" studies provide MRI data on 42 and 32 clinically unaffected co-twins respectively. The first used the criteria of Paty and associates3' for the MRI diagnosis of multiple sclerosis, the second criteria of Fazekas et al. 46 The MRI findings in these two studies are in agreement with our results (table 3) with less than 20% of asymptomatic subjects having scans suggestive of demyelination; neither were there significant differences between monozygotic and dizygotic co-twins.
Even if the presence of any MRI abnormality is taken for the purposes of this study to indicate multiple sclerosis in clinically unaf 
